According to the latest disclosure from the Beijing Stock Exchange, on September 8, 2026, the initial public offering status of Beijing Huamai Taike Medical Devices Co., Ltd. has been updated from "accepted" to "under inquiry."

This change marks a significant step forward in the company's listing journey, indicating that the exchange has officially commenced its review of the firm's submitted materials. The transition to the inquiry stage signals that regulators are now actively examining the details of the application, potentially paving the way for further procedural advancements in the near future.

For investors tracking the Chinese capital markets, this update underscores the steady progress of the medical device sector within the domestic listing pipeline, as the company continues to navigate the regulatory requirements set forth by the exchange.